Encompass Health Corp (EHC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $13.83B
Last updated: Nov 17, 2026 at 11:05 AM ET
Encompass Health Corp (EHC) Financials: Revenue, Profit and Cash Flow
Encompass Health reported revenue of $5.94B for the fiscal year ended Dec 31, 2025, up 10.5% from the year before. That year, net income was $759.10M with a net margin of 12.8%, operating cash flow was $1.18B and free cash flow was $439.20M. The quarter ended Sep 30, 2026 had revenue of $1.61B and net income of $203.60M.
Revenue and Margins
The operating margin was 17.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $3.64B, a compound annual rate of 5.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.94B | +10.5% | 46.5% | 17.7% | 12.8% |
| Dec 2024 | $5.37B | +11.9% | 44.9% | 16.1% | 11.1% |
| Dec 2023 | $4.80B | +10.4% | 44.7% | 15.2% | 9.6% |
| Dec 2022 | $4.35B | +8.3% | 43.7% | 14.5% | 8.4% |
| Dec 2021 | $4.01B | +12.6% | 45.5% | 16.4% | 12.9% |
| Dec 2020 | $3.57B | -22.6% | 44.9% | 14.8% | 10.3% |
| Dec 2019 | $4.61B | +7.7% | 42.3% | 15.0% | 9.7% |
| Dec 2018 | $4.28B | +9.3% | 45.0% | 14.7% | 6.8% |
| Dec 2017 | $3.91B | +7.4% | 45.0% | 16.6% | 6.9% |
| Dec 2016 | $3.64B | N/A | 45.5% | 17.8% | 6.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 27.2% from the year before. In the quarter ended Sep 2026, net income rose 16.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B |
| Cost of revenue | $3.17B | $2.96B | $2.66B | $2.45B | $2.19B | $1.97B | $2.66B | $2.35B | $2.15B | $1.99B |
| Gross profit | $2.76B | $2.41B | $2.14B | $1.90B | $1.83B | $1.60B | $1.95B | $1.92B | $1.76B | $1.66B |
| Operating income | $1.05B | $864.50M | $731.80M | $630.20M | $659.40M | $527.60M | $692.50M | $629.60M | $649.40M | $648.80M |
| Net income | $759.10M | $596.60M | $463.00M | $365.90M | $517.20M | $368.80M | $445.80M | $292.30M | $271.10M | $247.60M |
| EBITDA | $1.41B | $1.19B | $1.03B | $878.30M | $894.30M | $746.20M | $946.20M | $835.50M | $846.00M | $838.10M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.61B | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B |
| Gross profit | $753.80M | $762.40M | $753.30M | $729.00M | $677.80M | $675.30M | $678.20M | $633.50M | $604.50M | $586.50M | $590.40M | $556.50M |
| Operating income | $288.00M | $288.40M | $301.60M | $283.40M | $243.60M | $259.10M | $267.00M | $232.30M | $209.10M | $215.60M | $207.50M | $189.90M |
| Net income | $203.60M | $207.40M | $248.20M | $203.10M | $174.60M | $184.90M | $196.50M | $164.20M | $147.10M | $146.50M | $138.80M | $119.10M |
Balance Sheet
As of Dec 2025, total debt of $2.49B exceeded cash and equivalents by $2.42B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B | $6.45B | $6.08B | $5.17B | $2.09B | $4.68B |
| Current assets | $905.90M | $886.90M | $841.80M | $717.20M | $921.40M | $948.60M | $755.80M | $662.10M | $116.80M | $654.50M |
| Cash and equivalents | $72.20M | $85.40M | $69.10M | $21.80M | $49.40M | $224.00M | $94.80M | $69.20M | $54.40M | $40.50M |
| Total liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B | $4.44B | $4.15B | $3.36B | $0 | $3.61B |
| Short-term debt | $43.60M | $138.60M | $24.80M | $25.20M | $37.80M | $38.30M | $39.30M | $35.80M | $32.30M | $37.10M |
| Long-term debt | $2.45B | $2.36B | $2.69B | $2.74B | $3.24B | $3.25B | $3.02B | $2.48B | $2.55B | $2.98B |
| Shareholder equity | $0 | $2.07B | $1.65B | $1.31B | $1.91B | $1.59B | $1.35B | $1.28B | $0 | $735.90M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.57B | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B | $6.46B | $6.39B | $6.23B | $6.10B |
| Total liabilities | $4.01B | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | $3.70B | $3.69B | $3.73B | $3.86B | $3.83B | $3.81B |
| Cash and equivalents | $76.20M | $107.70M | $110.50M | $102.90M | $48.70M | $99.10M | $95.80M | $85.40M | $147.80M | $154.40M | $134.40M | $104.20M |
| Shareholder equity | $0 | $0 | $0 | $2.44B | $0 | $0 | $0 | $2.07B | $0 | $0 | $0 | $1.65B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 37.2% of operating cash flow. Dividends and share repurchases together came to 86.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.18B | $1.00B | $850.80M | $705.80M | $715.80M | $704.70M | $635.30M | $762.40M | $658.30M | $640.20M |
| Capital expenditures | $736.40M | $642.50M | $583.10M | $584.10M | $545.70M | $401.10M | $385.40M | $270.50M | $245.00M | $202.90M |
| Free cash flow | $439.20M | $360.30M | $267.70M | $121.70M | $170.10M | $303.60M | $249.90M | $491.90M | $413.30M | $437.30M |
| Dividends paid | $223.20M | $187.80M | $175.10M | $195.60M | $213.30M | $345.00M | $351.40M | $241.30M | $143.40M | $148.70M |
| Share repurchases | $158.00M | $31.10M | $0 | $0 | N/A | $6.10M | $45.90M | $0 | $38.10M | $65.60M |
| Investing cash flow | -$764.60M | -$653.30M | -$602.80M | -$627.00M | -$666.30M | -$407.50M | -$657.40M | -$424.50M | -$283.00M | -$229.90M |
| Financing cash flow | -$431.20M | -$330.60M | -$197.20M | -$145.70M | -$240.10M | -$145.90M | $48.20M | -$321.20M | -$359.90M | -$416.40M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $362.00M | $282.60M | $313.10M | $346.00M | $270.80M | $270.20M | $288.60M | $278.80M | $267.80M | $217.40M | $238.80M | $201.00M |
| Capital expenditures | $234.50M | $220.30M | $162.40M | $229.30M | $187.10M | $156.90M | $163.10M | $198.70M | $147.50M | $156.90M | $139.40M | $211.70M |
| Free cash flow | $127.50M | $62.30M | $150.70M | $116.70M | $83.70M | $113.30M | $125.50M | $80.10M | $120.30M | $60.50M | $99.40M | -$10.70M |
Frequently Asked Questions About EHC
What is Encompass Health's annual revenue?
Encompass Health reported revenue of $5.94B for the fiscal year ended Dec 31, 2025.
How fast is Encompass Health's revenue growing?
Revenue was up 10.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.9%.
Is Encompass Health profitable?
Yes. Encompass Health reported net income of $759.10M for the fiscal year ended Dec 31, 2025, with a net margin of 12.8%.
How much free cash flow does EHC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.18B minus capital expenditures of $736.40M produced free cash flow of $439.20M.
How much debt does Encompass Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.45B, short-term debt of $43.60M and cash and equivalents of $72.20M.
EHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts